Effective of hANP for CABG in patients with moderate to severe preoperative renal dysfunction without dialysis.
Latest Information Update: 28 Mar 2018
Price :
$35 *
At a glance
- Drugs Carperitide (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- Acronyms NU-HIT
- 26 Mar 2018 Status changed from active, no longer recruiting to completed.
- 18 Sep 2009 New trial record